Focus: Smith & Nephew is a public specialty medical device and pharmaceutical company headquartered in Andover, MA, focused on sports medicine, trauma, wound care, and select therapeutic areas. The company operates as a mature, publicly-traded entity with a diversified but heavily concentrated revenue base.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Smith and Nephew to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Cornerstone product representing 96% of company revenue; loss of exclusivity poses critical existential risk to the organization.
Help build intelligence for Smith and Nephew
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Smith and Nephew's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Secondary wound care asset with PDGF-mimetic mechanism; approaching LOE but contributes only 4% of revenue.
Generic anticoagulant in pre-launch phase; represents new lower-margin generic strategy.
102 discontinued, 1 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles